Pfizer gets reissue patent for Celebrex, sues generics makers
Pfizer Inc. has been granted a reissue patent from United States Patent & Trademark Office for methods of treating osteoarthritis and other approved conditions with celecoxib, the active ingredient in Celebrex. The reissue patent is slated to expire on Dec.